BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9344214)

  • 21. [Consensus document on bath-PUVA therapy. The Spanish Photobiology Group of the Spanish Academy of Dermatology and Venereology].
    Rodríguez-Granados MT; Carrascosa JM; Gárate T; Gómez-Díez S; Guimaraens-Juantorena D
    Actas Dermosifiliogr; 2007 Apr; 98(3):164-70. PubMed ID: 17504700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
    Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
    Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukoderma punctata following topical PUVAsol treatment.
    Fernandes NC; Pina JC
    An Bras Dermatol; 2010; 85(4):571-2. PubMed ID: 20944925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamic interaction with phototoxic plants during PUVA therapy.
    Puig L
    Br J Dermatol; 1997 Jun; 136(6):973-4. PubMed ID: 9217843
    [No Abstract]   [Full Text] [Related]  

  • 25. Flu-like syndrome, bronchoconstriction and fever caused by 5-methoxypsoralen: the first case report and literature review.
    Mantovani L; Minghetti S; Maranini C; Furicchia G; Borghi A; Virgili A
    Dermatology; 2011; 223(3):213-5. PubMed ID: 21576926
    [No Abstract]   [Full Text] [Related]  

  • 26. Improved prediction of the minimal phototoxic dose in PUVA therapy.
    Sakuntabhai A; Matthews JN; Farr PM
    Br J Dermatol; 1994 May; 130(5):604-9. PubMed ID: 8204468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: a randomized crossover trial.
    Tzaneva S; Kittler H; Holzer G; Reljic D; Weber M; Hönigsmann H; Tanew A
    Br J Dermatol; 2010 Mar; 162(3):655-60. PubMed ID: 19769631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral psoralen-UV-A for systemic scleroderma.
    Hofer A; Soyer HP
    Arch Dermatol; 1999 May; 135(5):603-4. PubMed ID: 10328211
    [No Abstract]   [Full Text] [Related]  

  • 29. PUVA therapy: current concerns in Japan.
    Danno K
    J Dermatol Sci; 1999 Feb; 19(2):89-105. PubMed ID: 10098700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracorporeal methoxsalen: new drug. Cutaneous T cell lymphoma: for rare patients, but better assessment needed.
    Prescrire Int; 2009 Feb; 18(99):16. PubMed ID: 19388212
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative evaluation of NBUVB phototherapy and PUVA photochemotherapy in chronic plaque psoriasis.
    Dayal S; ; Jain VK
    Indian J Dermatol Venereol Leprol; 2010; 76(5):533-7. PubMed ID: 20826993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma and buffy coat concentration of 8-methoxypsoralen in patients treated with extracorporeal photopheresis.
    Balogh A; Merkel U; Looks A; Vollandt R; Wollina U
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):397-401. PubMed ID: 9784014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An unusual cause of burn injury: unsupervised use of drugs that contain psoralens.
    Türegün M; Oztürk S; Selmanpakoğlu N
    J Burn Care Rehabil; 1999; 20(1 Pt 1):50-2. PubMed ID: 9934637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of psoralen-UV-B (311-nm) bath phototoxicity.
    Neumann NJ; Schlotmann K; Ruzicka T; Lehmann P
    Arch Dermatol; 1998 Oct; 134(10):1299-300. PubMed ID: 9801698
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy.
    Schempp CM; Müller H; Czech W; Schöpf E; Simon JC
    J Am Acad Dermatol; 1997 May; 36(5 Pt 1):733-7. PubMed ID: 9146535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis.
    Godt O; Proksch E; Streit V; Christophers E
    Dermatology; 1997; 195(1):35-9. PubMed ID: 9267734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of UVA irradiation following treatment with 8-methoxypsoralen on type I and type III collagen synthesis in normal and scleroderma fibroblast cultures.
    Kitamura Y; Namikawa H; Hayashi S; Yoshida T; Suzuki T; Hamasaki Y; Yamazaki S; Hatamochi A
    Arch Dermatol Res; 2009 Aug; 301(7):507-13. PubMed ID: 19343355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic actinic dermatitis: successful treatment with psoralen-ultraviolet A photochemotherapy.
    Chee SN; Novakovic L; Fassihi H; Garibaldinos T; Sarkany R
    Br J Dermatol; 2018 Mar; 178(3):e189-e190. PubMed ID: 28889653
    [No Abstract]   [Full Text] [Related]  

  • 39. Methoxsalen with ultraviolet A therapy (PUVA).
    Rep Carcinog; 2004; 11():III165-6. PubMed ID: 21089901
    [No Abstract]   [Full Text] [Related]  

  • 40. Retinoic acid for treatment of systemic sclerosis and morphea: A literature review.
    Thomas RM; Worswick S; Aleshin M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28032675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.